TY - JOUR
T1 - Hematopoietic stem cell therapy of autoimmune diseases
AU - Burt, Richard K.
AU - Traynor, Ann
PY - 1998/1/1
Y1 - 1998/1/1
N2 - Hematopoietic stem cell transplantation is a new therapy for severe autoimmune diseases. Patients who have failed standard therapies and are at high risk of subsequent morbidity and mortality are being considered as candidates. Early results are encouraging. However, the number of patients treated is limited, only short-term follow-up is available, the mechanism of improvement or stabilization is unknown, and the procedure has the potential for life-threatening toxicity.
AB - Hematopoietic stem cell transplantation is a new therapy for severe autoimmune diseases. Patients who have failed standard therapies and are at high risk of subsequent morbidity and mortality are being considered as candidates. Early results are encouraging. However, the number of patients treated is limited, only short-term follow-up is available, the mechanism of improvement or stabilization is unknown, and the procedure has the potential for life-threatening toxicity.
UR - http://www.scopus.com/inward/record.url?scp=0031798460&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031798460&partnerID=8YFLogxK
U2 - 10.1097/00062752-199811000-00020
DO - 10.1097/00062752-199811000-00020
M3 - Article
C2 - 9814658
AN - SCOPUS:0031798460
SN - 1065-6251
VL - 5
SP - 472
EP - 477
JO - Current Opinion in Hematology
JF - Current Opinion in Hematology
IS - 6
ER -